RNTX

REIN THERAPEUTICS INC

RNTX·00887A204·US·Common Stock·Healthcare - Biotechnology-13D/G

RNTX (REIN THERAPEUTICS INC) is held by 17 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($448,185), VANGUARD FIDUCIARY TRUST CO ($200,866). Net institutional sentiment: Mixed.

17
Holders
(2 Elite)
$2.4M
Total Value
50% (20)
Consensus
10 buying - 10 selling
13F: Insider & Congress:
RNTX

Smart Money Verdict

View all
Held by 17 funds
2 elite

Who's Trading

ActivistVOVoss Capital, LP6.6%Jul 14, 2026
ActivistBIBIOS CAPITAL MANAGEMENT, LP10.0%May 8, 2026
ActivistLYLynwood Capital Management Inc.6.1%May 8, 2026
ActivistFUFunicular Funds, LP6.7%May 7, 2026
ActivistLLLYTTON LAURENCE W5.8%May 6, 2026
InsiderWBWINDSOR JAMES BRIANBuy $25KApr 30, 2026
ActivistVVVoss Value Master Fund, LP3.5%Feb 13, 2026
InsiderVLVoss Capital, LPBuy $128KNov 14, 2025
InsiderVLVoss Capital, LPBuy $248KOct 28, 2025
InsiderVLVoss Capital, LPBuy $127KOct 27, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
998,521$1.3M0.0%-28.91%
39
Increased
344,690(+21.1%)$448,1850.0%-66.69%
20
New
154,512$200,8660.0%-28.91%
32
Unchanged
75,904$98,6750.0%-41.41%
0
Increased
68,528(+24.6%)$89,0870.0%-59.61%
18
Increased
64,136(+58.5%)$83,3770.0%-54.13%
21
Unchanged
42,440$55,1720.0%-47.02%
0
Increased
35,461(+97.4%)$46,0990.0%-27.85%
33
New
32,924$42,8010.0%-28.91%
28
Increased
24,500(+7.9%)$31,8500.0%-28.01%
14
New
12,774$16,6060.0%-28.91%
28
Unchanged
10,000$13,0000.0%-23.60%
0
Unchanged
5,097$6,6260.0%-28.91%
0
Unchanged
1,250$1,6250.0%-65.51%
0
Decreased
1,024(-89.2%)$1,3310.0%-23.95%
0
New
20$260.0%-28.91%
17
Decreased
15,486(-53.4%)$200.0%-23.60%
0
Exited
0(-100.0%)$14,3420.0%-21.77%
0
Exited
0(-100.0%)$48,3820.0%+7.48%
0
Exited
0(-100.0%)$490.0%-48.93%
0

Showing 1-20 of 25

1 / 2
RNTXRNTXREIN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used